Martin Wisher und Biosafety - Info zur Person

(1 - 10 von 10

)

제1회 생명공학제품 개발을 위한 국제 심포지움(11/17)newsmp.com

www.newsmp.com

15: :10 Dr. Martin Wisher (Bioreliance Co. UK) : Evaluation technology for Biosafety validation of Biologicals 16: :40 Dr. Sue N. Park (KFDA, ...

2017 Vaccines Process Development & Commercialization Workshop

web.mit.edu

Martin Wisher, PhD view abstract | back to agenda. Head of Regulatory Affairs, BioReliance. Dr. Wisher has more than 30 years of experience in biosafety ...

Moving your Gene Therapy from R&D to INDSlideShare

www.slideshare.net

— 15 Biosafety Risk Mitigation Strategy Martin Wisher (2018). Viral Risk Mitigation: A Global Regulatory Perspective.

Biosafety and product release testing issues relevant to...

www.nature.com

Replication competent oncolytic viruses, like other biological products, are at risk from contamination by bacteria, fungi, mycoplasma and viruses that must be...

Biosafety and product release testing issues relevant to replication ...www.nature.com › ... › review › article

www.nature.com

· Biosafety and product release testing issues relevant to replication-competent oncolytic viruses. Martin Wisher. Cancer Gene Therapy volume

Bioprocessing - Single Use SystemsThe Medicine Maker

themedicinemaker.com

Manufacture Bioprocessing - Upstream & Downstream · MilliporeSigma: A Biosafety Revolution | Afshin Sohrabi, Audrey Chang, Martin Wisher.

Biosafety and product release testing issues relevant to ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von M Wisher · · Zitiert von: 41 — Author. Martin Wisher. Affiliation. 1 BioReliance, Innovation Park, Stirling, UK. . PMID: ; DOI: sj.cgt

Biosafety and product release testing issues relevant to ...ebsco

search.ebscohost.com

von M Wisher · · Zitiert von: 41 — Martin Wisher. BioReliance, Innovation Park, Stirling, UK. Replication competent oncolytic viruses, like other biological products, are at risk from ...

Merck: A Biosafety Revolution - The Medicine Makerthemedicinemaker.com › Manufacture

themedicinemaker.com

· Martin Wisher. Martin Wisher is Senior Regulatory Consultant. He focuses on the BioReliance® biosafety portfolio at Merck. Related White ...

Alle Infos zum Namen "Martin Wisher"

Verwandte Suchanfragen zu Martin Wisher

Audrey Chang
Gene Therapy
Mike Rubino

Robert Bird

Personen
Vorname "Martin" (86745)
Name "Wisher" (6)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Martin Wisher und Biosafety Person-Info